The Prognostic Role of Candidate Serum Biomarkers in the Post-Acute and Chronic Phases of Disorder of Consciousness: A Preliminary Study

Introduction: Serum biomarkers, such as Neurofilament Light (NF-L), Glial Fibrillary Acidic Protein (GFAP), Ubiquitin C-terminal Hydrolase (UCH-L1), and Total-tau (T-Tau) have been proposed for outcome prediction in the acute phase of severe traumatic brain injury, but they have been less investigat...

Full description

Bibliographic Details
Main Authors: Rita Formisano, Mariagrazia D’Ippolito, Marco Giustini, Sheila Catani, Stefania Mondello, Iliana Piccolino, Filomena Iannuzzi, Kevin K. Wang, Ronald L. Hayes
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/14/3/239
_version_ 1797241810483937280
author Rita Formisano
Mariagrazia D’Ippolito
Marco Giustini
Sheila Catani
Stefania Mondello
Iliana Piccolino
Filomena Iannuzzi
Kevin K. Wang
Ronald L. Hayes
author_facet Rita Formisano
Mariagrazia D’Ippolito
Marco Giustini
Sheila Catani
Stefania Mondello
Iliana Piccolino
Filomena Iannuzzi
Kevin K. Wang
Ronald L. Hayes
author_sort Rita Formisano
collection DOAJ
description Introduction: Serum biomarkers, such as Neurofilament Light (NF-L), Glial Fibrillary Acidic Protein (GFAP), Ubiquitin C-terminal Hydrolase (UCH-L1), and Total-tau (T-Tau) have been proposed for outcome prediction in the acute phase of severe traumatic brain injury, but they have been less investigated in patients with prolonged DoC (p-DoC). Methods: We enrolled 25 p-DoC patients according to the Coma Recovery Scale-Revised (CRS-R). We identified different time points: injury onset (t<sub>0</sub>), first blood sampling at admission in Neurorehabilitation (t<sub>1</sub>), and second blood sampling at discharge (t<sub>2</sub>). Patients were split into improved (improved level of consciousness from t<sub>1</sub> to t<sub>2</sub>) and not-improved (unchanged or worsened level of consciousness from t<sub>1</sub> to t<sub>2</sub>). Results: All biomarker levels decreased over time, even though each biomarker reveals typical features. Serum GFAP showed a weak correlation between t<sub>1</sub> and t<sub>2</sub> (<i>p</i> = 0.001), while no correlation was observed for serum NF-L (<i>p</i> = 0.955), UCH-L1 (<i>p</i> = 0.693), and T-Tau (<i>p</i> = 0.535) between t<sub>1</sub> and t<sub>2</sub>. Improved patients showed a significant decrease in the level of NF-L (<i>p</i> = 0.0001), UCH-L1 (<i>p</i> = 0.001), and T-Tau (<i>p</i> = 0.002), but not for serum GFAP (<i>p</i> = 0.283). No significant statistical differences were observed in the not-improved group. Conclusions: A significant correlation was found between the level of consciousness improvement and decreased NF-L, UCH-L1, and T-Tau levels. Future studies on the association of serum biomarkers with neurophysiological and neuroimaging prognostic indicators are recommended.
first_indexed 2024-04-24T18:29:15Z
format Article
id doaj.art-9d115c3d21dd41f490803e9b9eae63eb
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-04-24T18:29:15Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-9d115c3d21dd41f490803e9b9eae63eb2024-03-27T13:28:44ZengMDPI AGBrain Sciences2076-34252024-02-0114323910.3390/brainsci14030239The Prognostic Role of Candidate Serum Biomarkers in the Post-Acute and Chronic Phases of Disorder of Consciousness: A Preliminary StudyRita Formisano0Mariagrazia D’Ippolito1Marco Giustini2Sheila Catani3Stefania Mondello4Iliana Piccolino5Filomena Iannuzzi6Kevin K. Wang7Ronald L. Hayes8Neurorehabilitation 2, Post-Coma Unit, IRCCS Fondazione Santa Lucia, 00179 Rome, ItalyNeurorehabilitation 2, Post-Coma Unit, IRCCS Fondazione Santa Lucia, 00179 Rome, ItalyEnvironmental and Social Epidemiology Unit, National Institute of Health, 00161 Rome, ItalyMultiple Sclerosis Unit, IRCCS Fondazione Santa Lucia, 00179 Rome, ItalyDepartment of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, 98122 Messina, ItalyExperimental Neuro-Psychobiology Laboratory, IRCCS Fondazione Santa Lucia, 00179 Rome, ItalyExperimental Neuro-Psychobiology Laboratory, IRCCS Fondazione Santa Lucia, 00179 Rome, ItalyDepartment of Neurobiology, Center for Neurotrauma, Multiomics & Biomarkers (CNMB), Neuroscience Institute, Morehouse School of Medicine, Atlanta, GE 30310, USABanyan Biomarkers Inc., Alachua, FL 32615, USAIntroduction: Serum biomarkers, such as Neurofilament Light (NF-L), Glial Fibrillary Acidic Protein (GFAP), Ubiquitin C-terminal Hydrolase (UCH-L1), and Total-tau (T-Tau) have been proposed for outcome prediction in the acute phase of severe traumatic brain injury, but they have been less investigated in patients with prolonged DoC (p-DoC). Methods: We enrolled 25 p-DoC patients according to the Coma Recovery Scale-Revised (CRS-R). We identified different time points: injury onset (t<sub>0</sub>), first blood sampling at admission in Neurorehabilitation (t<sub>1</sub>), and second blood sampling at discharge (t<sub>2</sub>). Patients were split into improved (improved level of consciousness from t<sub>1</sub> to t<sub>2</sub>) and not-improved (unchanged or worsened level of consciousness from t<sub>1</sub> to t<sub>2</sub>). Results: All biomarker levels decreased over time, even though each biomarker reveals typical features. Serum GFAP showed a weak correlation between t<sub>1</sub> and t<sub>2</sub> (<i>p</i> = 0.001), while no correlation was observed for serum NF-L (<i>p</i> = 0.955), UCH-L1 (<i>p</i> = 0.693), and T-Tau (<i>p</i> = 0.535) between t<sub>1</sub> and t<sub>2</sub>. Improved patients showed a significant decrease in the level of NF-L (<i>p</i> = 0.0001), UCH-L1 (<i>p</i> = 0.001), and T-Tau (<i>p</i> = 0.002), but not for serum GFAP (<i>p</i> = 0.283). No significant statistical differences were observed in the not-improved group. Conclusions: A significant correlation was found between the level of consciousness improvement and decreased NF-L, UCH-L1, and T-Tau levels. Future studies on the association of serum biomarkers with neurophysiological and neuroimaging prognostic indicators are recommended.https://www.mdpi.com/2076-3425/14/3/239acquired brain injuryprolonged disorders of consciousnessserum biomarkers
spellingShingle Rita Formisano
Mariagrazia D’Ippolito
Marco Giustini
Sheila Catani
Stefania Mondello
Iliana Piccolino
Filomena Iannuzzi
Kevin K. Wang
Ronald L. Hayes
The Prognostic Role of Candidate Serum Biomarkers in the Post-Acute and Chronic Phases of Disorder of Consciousness: A Preliminary Study
Brain Sciences
acquired brain injury
prolonged disorders of consciousness
serum biomarkers
title The Prognostic Role of Candidate Serum Biomarkers in the Post-Acute and Chronic Phases of Disorder of Consciousness: A Preliminary Study
title_full The Prognostic Role of Candidate Serum Biomarkers in the Post-Acute and Chronic Phases of Disorder of Consciousness: A Preliminary Study
title_fullStr The Prognostic Role of Candidate Serum Biomarkers in the Post-Acute and Chronic Phases of Disorder of Consciousness: A Preliminary Study
title_full_unstemmed The Prognostic Role of Candidate Serum Biomarkers in the Post-Acute and Chronic Phases of Disorder of Consciousness: A Preliminary Study
title_short The Prognostic Role of Candidate Serum Biomarkers in the Post-Acute and Chronic Phases of Disorder of Consciousness: A Preliminary Study
title_sort prognostic role of candidate serum biomarkers in the post acute and chronic phases of disorder of consciousness a preliminary study
topic acquired brain injury
prolonged disorders of consciousness
serum biomarkers
url https://www.mdpi.com/2076-3425/14/3/239
work_keys_str_mv AT ritaformisano theprognosticroleofcandidateserumbiomarkersinthepostacuteandchronicphasesofdisorderofconsciousnessapreliminarystudy
AT mariagraziadippolito theprognosticroleofcandidateserumbiomarkersinthepostacuteandchronicphasesofdisorderofconsciousnessapreliminarystudy
AT marcogiustini theprognosticroleofcandidateserumbiomarkersinthepostacuteandchronicphasesofdisorderofconsciousnessapreliminarystudy
AT sheilacatani theprognosticroleofcandidateserumbiomarkersinthepostacuteandchronicphasesofdisorderofconsciousnessapreliminarystudy
AT stefaniamondello theprognosticroleofcandidateserumbiomarkersinthepostacuteandchronicphasesofdisorderofconsciousnessapreliminarystudy
AT ilianapiccolino theprognosticroleofcandidateserumbiomarkersinthepostacuteandchronicphasesofdisorderofconsciousnessapreliminarystudy
AT filomenaiannuzzi theprognosticroleofcandidateserumbiomarkersinthepostacuteandchronicphasesofdisorderofconsciousnessapreliminarystudy
AT kevinkwang theprognosticroleofcandidateserumbiomarkersinthepostacuteandchronicphasesofdisorderofconsciousnessapreliminarystudy
AT ronaldlhayes theprognosticroleofcandidateserumbiomarkersinthepostacuteandchronicphasesofdisorderofconsciousnessapreliminarystudy
AT ritaformisano prognosticroleofcandidateserumbiomarkersinthepostacuteandchronicphasesofdisorderofconsciousnessapreliminarystudy
AT mariagraziadippolito prognosticroleofcandidateserumbiomarkersinthepostacuteandchronicphasesofdisorderofconsciousnessapreliminarystudy
AT marcogiustini prognosticroleofcandidateserumbiomarkersinthepostacuteandchronicphasesofdisorderofconsciousnessapreliminarystudy
AT sheilacatani prognosticroleofcandidateserumbiomarkersinthepostacuteandchronicphasesofdisorderofconsciousnessapreliminarystudy
AT stefaniamondello prognosticroleofcandidateserumbiomarkersinthepostacuteandchronicphasesofdisorderofconsciousnessapreliminarystudy
AT ilianapiccolino prognosticroleofcandidateserumbiomarkersinthepostacuteandchronicphasesofdisorderofconsciousnessapreliminarystudy
AT filomenaiannuzzi prognosticroleofcandidateserumbiomarkersinthepostacuteandchronicphasesofdisorderofconsciousnessapreliminarystudy
AT kevinkwang prognosticroleofcandidateserumbiomarkersinthepostacuteandchronicphasesofdisorderofconsciousnessapreliminarystudy
AT ronaldlhayes prognosticroleofcandidateserumbiomarkersinthepostacuteandchronicphasesofdisorderofconsciousnessapreliminarystudy